This website is intended for healthcare professionals only.
Prof. Sylvie Lorenzen
MD, PHD
HEAD OF THE PHASE I UNIT, UNIVERSITY HOSPITAL RECHTS DER ISAR,
TECHNICAL UNIVERSITY OF MUNICH, GERMANY
About Our Speaker
Prof Lorenzen’s research interests include clinical research in medical oncology, response evaluation in solid tumor therapy and multimodality treatment of gastrointestinal cancer. She is the head of the gastroesophageal working group of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
Related Webinars
Patient's voice matters - shared decisions in 3L mGC
Real-world evidence highlights the importance of 3L- and 4L- treatment selection to improve mCRC patients outcomes.
New evidence on 3L mGC, applied to daily practice
Sequential treatment strategy in mGC and optimization of patients outcomes in 3L and beyond.
Addressing the unmet needs in 3L mGC a clinical perspective
Sequential treatment strategy in mGC and optimization of patients outcomes in 3L.
